Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1981-05-27
1984-02-14
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, A61K 4300, A61K 4900
Patent
active
044316267
ABSTRACT:
Novel radionuclide imaging agents, having particular application for lymphangiography are provided by non-covalently binding Tc-99m to a pharmaceutically acceptable cross-linked polysaccharide. Upon injection of the Tc-99m labeled polysaccharide into the blood stream, optimum contrast can be obtained within one hour.
REFERENCES:
patent: 2653931 (1953-09-01), Isbell
patent: 2677645 (1954-05-01), Allen
patent: 3758678 (1973-09-01), Lindsay et al.
patent: 3852413 (1974-12-01), Cammarata
patent: 4002730 (1977-01-01), Hartman et al.
patent: 4106488 (1978-08-01), Gordon
patent: 4124705 (1978-11-01), Rothman et al.
patent: 4126669 (1978-11-01), Rothman et al.
patent: 4303636 (1981-12-01), Gordon
patent: 4359453 (1982-11-01), Gordon
Steigman et al., J. Label. Comp. Radiopharm., 16: 83-85.
Johnson et al., J. Biol. Nucl. Med., 11: 103-106, (1967).
Hamilton et al., Experientia, 34: 582-583, (1978).
Nucker Christine M.
Rowland Bertram I.
The Regents of the University of California
LandOfFree
Tc-99m Labeled carrier for imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tc-99m Labeled carrier for imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tc-99m Labeled carrier for imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2374716